+35%

est. 2Y upside i

HealthcareSeries D+

Grow Therapy is an online platform that connects patients with therapists that are covered by insurance.

Rank

#1144

Sector

Digital Health / Mental Health Marketplace

Est. Liquidity

~2Y

Data Quality

Data: Medium

Grow Therapy is the fastest-scaling mental health marketplace: $1B ARR at 100% growth, $3B val (3x rev).

Last updated: March 21, 2026

Bull (30%)+200%

$2B+ ARR by 2027. IPO at 5-8x ($10-16B). Becomes mental health infrastructure layer.

Base (45%)+60%

$1.5B ARR. IPO at 3-5x ($4.5-7.5B). Strong from $3B entry.

Bear (25%)-30%

Headway wins; reimbursement rates compress; therapist churn. IPO at $2-2.5B.

Est. time to liquidity~2.0 years

Preference Stack Risk

moderate

Funding Intensity

13%

$388M raised on $3B = 12.9% intensity. Clean.

Dilution Risk

low

Series D recent; IPO next.

Secondary Liquidity

limited

Pre-IPO secondary possible.

Other — 37 roles

View all 37 open roles at Grow Therapy →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Grow Therapy's data — designed to show you've done your homework.

  • 1

    “Net take-rate and path to gross margin improvement?”

  • 2

    “Headway competitive win rate?”

  • 3

    “IPO timeline?”

Community

Valuation Sentiment

Our model estimates +35% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.